

Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Among its major competitors, Karyopharm Therapeutics is ranked in 1st place for NPS while Alkermes is 2nd, and Janssen is 3rd. Overall, Karyopharm Therapeutics has a neutral social sentiment, when analyzing social media channels and online mentions.Their current market cap is $753.30M
Karyopharm Therapeutics's Net Promoter Score (NPS) is a 100 with 100% Promoters, 0% Passives, and 0% Detractors. Net Promoter Score tracks whether Karyopharm Therapeutics's customers would recommend using the product based on a scale of -100 to 100.
| 100% | Promoters |
|---|---|
| 0% | Passives |
| 0% | Detractors |
| Summary | Date | Score |
|---|---|---|
Apr 2021 100 | Apr 2021 | 100 |
Karyopharm Therapeutics is ranked first for NPS among its competitors. Bristol Myers Squibb and Amgen come in second and third, with Biogen coming in at #4. Among those competitors, it is the lowest valued company behind Amgen.
![]() Karyopharm Therapeutics | ![]() Bristol Myers Squibb | ![]() Biogen | ![]() Amgen | |
| Global Ranking | #- | #205 | #388 | #- |
| NPS | 100 | 27 | 21 | 24 |
| Social Sentiment Calculated by analyzing social media and other online mentions | Neutral | Neutral | Neutral | - |
| Valuation Updated every 24 hours for public companies | $753.30M | $140.58B | $42.46B | $145.56B |
Net Promoter Score (NPS) is a management tool that can be used to gauge the satisfaction of a firm's customer relationships. NPS has been widely adopted as a key metric often linked to the revenue potential of a company’s product or service. The metric is based on customer responses to the question: "On a scale of 0 to 10, how likely are you to recommend the product to a friend?"
Those who respond with a score of 9 to 10 are known as Promoters, and are widely associated with behaviors that create value, including actively encouraging others to use the product or service. Those who respond with a score of 7 or 8 are categorized as Passives, and they are believed to be less likely to exhibit the value-creation traits of Promoters having a largely neutral effect on other consumers. Detractors are those who fall in the score range of 0 to 6 and represent dissatisfied customers of the product sometimes actively recommending against using the product.
Compared to its competitors, Karyopharm Therapeutics's NPS is rated right above Alkermes.
| COMPANY | NPS Score | |
|---|---|---|
![]() | Karyopharm Therapeutics | 100 |
![]() | Alkermes | 47 |
![]() | Janssen | 46 |
![]() | Vertex Pharmaceuticals | 34 |
![]() | Agios Pharmaceuticals | 34 |
![]() | Bristol Myers Squibb | 27 |
![]() | Takeda | 27 |
![]() | Amgen | 24 |
![]() | Sanofi | 21 |
![]() | Biogen | 21 |
![]() | Ironwood Pharmaceuticals | N/A |
![]() | Sarepta Therapeutics | -9 |
Customer Loyalty is a strong indicator of whether or not a customer will choose a brand repeatedly over a competitor that offers similar products/services.
100% of Karyopharm Therapeutics users/customers answered "Yes" when asked: "Would you consider yourself a loyal user/customer?"
Sign Up to see the full customer demographics data and the people that answered "Yes" when asked "Would you consider yourself a loyal user/customer?"
Compared to its competitors, Karyopharm Therapeutics's Customer Loyalty score is rated right above Agios Pharmaceuticals.
| COMPANY | Customer Loyalty Score | |
|---|---|---|
![]() | Karyopharm Therapeutics | 100% |
![]() | Agios Pharmaceuticals | 100% |
![]() | Sarepta Therapeutics | 100% |
![]() | Janssen | 79% |
![]() | Bristol Myers Squibb | 79% |
![]() | Amgen | 77% |
![]() | Vertex Pharmaceuticals | 76% |
![]() | Takeda | 76% |
![]() | Sanofi | 75% |
![]() | Biogen | 75% |
![]() | Alkermes | 64% |
![]() | Ironwood Pharmaceuticals | N/A |
Karyopharm Therapeutics has an overall Product Quality score of 5 out of 5 stars rated by its users and customers.
Sign Up to unlock Karyopharm Therapeutics' overall Product Quality score rated by its users and customers.
Karyopharm Therapeutics’s product quality score is a 5 out of 5 as rated by its users and customers.
Compared to its competitors, Karyopharm Therapeutics's Product Quality score is rated right above Takeda.
| COMPANY | Product Quality Score | |
|---|---|---|
![]() | Karyopharm Therapeutics | 5/5 |
![]() | Takeda | 4.1/5 |
![]() | Alkermes | 4/5 |
![]() | Biogen | 4/5 |
![]() | Sanofi | 4/5 |
![]() | Bristol Myers Squibb | 3.9/5 |
![]() | Amgen | 3.8/5 |
![]() | Sarepta Therapeutics | 3.7/5 |
![]() | Janssen | 3.7/5 |
![]() | Vertex Pharmaceuticals | 3.5/5 |
![]() | Agios Pharmaceuticals | 1.5/5 |
![]() | Ironwood Pharmaceuticals | N/A |
Karyopharm Therapeutics has a value for money and ROI score of 5 out of 5 stars rated by its users and customers.
Sign Up to unlock Karyopharm Therapeutics' overall ROI score rated by its users and customers.
Compared to its competitors, Karyopharm Therapeutics's ROI score is rated right above Agios Pharmaceuticals.
| COMPANY | Pricing Score | |
|---|---|---|
![]() | Karyopharm Therapeutics | 5/5 |
![]() | Agios Pharmaceuticals | 5/5 |
![]() | Alkermes | 4/5 |
![]() | Vertex Pharmaceuticals | 4/5 |
![]() | Takeda | 3.9/5 |
![]() | Sanofi | 3.8/5 |
![]() | Biogen | 3.8/5 |
![]() | Amgen | 3.8/5 |
![]() | Sarepta Therapeutics | 3.7/5 |
![]() | Bristol Myers Squibb | 3.7/5 |
![]() | Janssen | 3.5/5 |
![]() | Ironwood Pharmaceuticals | N/A |
Karyopharm Therapeutics has an overall Customer Service score of 5 out of 5 stars rated by its users and customers.
Sign Up to unlock Karyopharm Therapeutics' overall Customer Service score rated by its users and customers.
Newton, MA 02459
http://www.karyopharm.com
+1 (617) 658-0600
Compared to its competitors, Karyopharm Therapeutics's Customer Service score is rated right above Sarepta Therapeutics.
| COMPANY | Customer Service Score | |
|---|---|---|
![]() | Karyopharm Therapeutics | 5/5 |
![]() | Sarepta Therapeutics | 5/5 |
![]() | Alkermes | 4.2/5 |
![]() | Takeda | 4/5 |
![]() | Vertex Pharmaceuticals | 3.9/5 |
![]() | Amgen | 3.9/5 |
![]() | Sanofi | 3.9/5 |
![]() | Bristol Myers Squibb | 3.8/5 |
![]() | Biogen | 3.8/5 |
![]() | Janssen | 3.5/5 |
![]() | Agios Pharmaceuticals | 2.5/5 |
![]() | Ironwood Pharmaceuticals | N/A |
Karyopharm Therapeutics has a 4.5/5 stars for its overall company culture rated by their employees

In the Top 5% of Similar Sized Companies on Comparably.
Karyopharm Therapeutics scored a 100 for Net Promoter Score and a 10 for Employee Net Promoter Score. NPS gauges how likely a customer of Karyopharm Therapeutics would recommend the brand to a friend. ENPS measures how likely Karyopharm Therapeutics employees would recommend working at Karyopharm Therapeutics to a friend.
| 100% | Promoters |
|---|---|
| 0% | Passive |
| 0% | Detractors |
| 38% | Promoters |
|---|---|
| 34% | Passive |
| 28% | Detractors |